Cargando…

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults

Cenobamate (CNB) is the latest antiseizure medication (ASM) authorized for the treatment of focal-onset seizures in adults. Although the precise mechanism of action of CNB is not yet fully understood, this drug inhibits the persistent, rather than transient, voltage-gated sodium channel currents and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaccara, Gaetano, Lattanzi, Simona, Leo, Antonio, Russo, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643217/ https://www.ncbi.nlm.nih.gov/pubmed/34876814 http://dx.doi.org/10.2147/NDT.S281490

Ejemplares similares

Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis
por: Lattanzi, Simona, et al.
Publicado: (2020)

New evidence in adjunctive treatment of focal-onset seizures in adults: a critical appraisal
por: Lattanzi, Simona
Publicado: (2022)

Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis
por: Lattanzi, Simona, et al.
Publicado: (2022)

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
por: Chung, Steve S., et al.
Publicado: (2020)

Effectiveness and safety of adjunctive cenobamate for focal seizures in adults with developmental disability treated in clinical practice
por: Connor, Gregory S., et al.
Publicado: (2022)

Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy
por: Singh, Alok
Publicado: (2022)

Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
por: Klein, Pavel, et al.
Publicado: (2022)

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
por: Sperling, Michael R., et al.
Publicado: (2020)

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
por: French, Jacqueline A., et al.
Publicado: (2021)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
por: Schmitz, Bettina, et al.
Publicado: (2023)

Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
por: Falcicchio, Giovanni, et al.
Publicado: (2022)

Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program
por: Sander, Josemir W., et al.
Publicado: (2021)

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Vossler, David G.
Publicado: (2020)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
por: Villanueva, Vicente, et al.
Publicado: (2023)

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study
por: Sperling, Michael R., et al.
Publicado: (2021)

Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
por: Melnick, Susan M., et al.
Publicado: (2023)

Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy
por: Lattanzi, Simona, et al.
Publicado: (2018)

Adjunctive therapy for severe malaria: a review and critical appraisal
por: Varo, Rosauro, et al.
Publicado: (2018)

Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
por: Rosenfeld, William E., et al.
Publicado: (2021)

Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
por: Väätäinen, Saku, et al.
Publicado: (2019)

Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
por: Farkas, Viktor, et al.
Publicado: (2019)

Efficacy of Retigabine in Adjunctive Treatment of Partial Onset Seizures in Adults
por: Splinter, Michele Y.
Publicado: (2013)

Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes
por: French, Jacqueline, et al.
Publicado: (2016)

Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABA(A) Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications
por: Latimer, Dustin R., et al.
Publicado: (2021)

Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
por: Mumoli, Laura, et al.
Publicado: (2015)

Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction
por: Friedo, Anna-Lena, et al.
Publicado: (2023)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Clinical utility of adjunctive retigabine in partial onset seizures in adults
por: Rejdak, Konrad, et al.
Publicado: (2012)

Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective
por: Hu, Yani, et al.
Publicado: (2022)

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
por: Löscher, Wolfgang, et al.
Publicado: (2021)

Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)
por: Kasteleijn- Nolst Trenite, Dorothee G.A., et al.
Publicado: (2019)

An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes
por: Ferrari, Louis, et al.
Publicado: (2020)

Onset of efficacy and adverse events during Cenobamate titration period
por: Steinhoff, Bernhard J., et al.
Publicado: (2022)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
por: Makridis, Konstantin L., et al.
Publicado: (2022)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
por: Jin, Yang, et al.
Publicado: (2023)

Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?
por: Zaccara, Gaetano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_etutrl1l65poqir5rbgtcp306d